Publication date: Jul 10, 2025
These results position delpazolid as a promising alternative to linezolid for future TB treatment regimenspending confirmation in larger studies. “Despite its effectiveness, linezolid is simply too toxic for many patients. Editors have highlighted the following attributes while ensuring the content’s credibility:Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Without the collaboration within PanACEA, this would not have been possible in such a short time. This article has been reviewed according to Science X’s editorial process and policies . It highlights the importance of tackling TB as a global community. “
| Concepts | Keywords |
|---|---|
| Munich | Clinical |
| Mycobacterium | Combination |
| Therapy | Delpazolid |
| Tropical | Dose |
| Drug | |
| Drugs | |
| Findings | |
| Linezolid | |
| Panacea | |
| Patients | |
| Promising | |
| Sutezolid | |
| Tb | |
| Treatment | |
| Trials |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Linezolid |
| disease | MESH | Infectious Diseases |
| disease | IDO | role |
| disease | MESH | Infection |
| drug | DRUGBANK | Bedaquiline |
| drug | DRUGBANK | Pretomanid |
| drug | DRUGBANK | Moxifloxacin |
| disease | MESH | anemia |
| drug | DRUGBANK | Spinosad |
| drug | DRUGBANK | Delamanid |
| disease | IDO | blood |
| drug | DRUGBANK | Tropicamide |
| drug | DRUGBANK | Sutezolid |
| disease | IDO | bacteria |
| disease | IDO | process |
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
(Visited 4 times, 1 visits today)